Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 17, 2014 09:15 ET | Source: Daré Bioscience, Inc.

Cerulean Pharma to Present at JMP Securities Healthcare Conference

CAMBRIDGE, Mass., June 17, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced that Christopher D. T. Guiffre, J.D., Senior Vice...
June 09, 2014 18:00 ET | Source: Daré Bioscience, Inc.

Mark E. Davis Presents Information About Cerulean's Lead Candidate, CRLX101, at 2014 ASCO Annual Meeting

CAMBRIDGE, Mass., June 9, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced that Mark E. Davis, Ph.D., Professor of Chemical...
June 03, 2014 09:00 ET | Source: Daré Bioscience, Inc.

Cerulean Announces CRLX101 Combination Data at 2014 ASCO Annual Meeting

CHICAGO, June 3, 2014 (GLOBE NEWSWIRE) -- ASCO Annual Meeting: Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, announced today that three abstracts on its lead...
May 27, 2014 20:14 ET | Source: Daré Bioscience, Inc.

Cerulean Reports First Quarter 2014 Corporate Highlights and Financial Results

CAMBRIDGE, Mass., May 27, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today provided an update on corporate activities during the quarter...
May 07, 2014 16:01 ET | Source: Daré Bioscience, Inc.

Cerulean Pharma Announces Exercise of Over-Allotment Option

CAMBRIDGE, Mass., May 7, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU) today announced that the underwriters for its initial public offering of common stock have exercised their...
April 15, 2014 10:50 ET | Source: Daré Bioscience, Inc.

Cerulean Pharma Announces Closing of Initial Public Offering

CAMBRIDGE, Mass., April 15, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU) today announced the closing of its initial public offering of 8,500,000 shares of its common stock at a public...
April 10, 2014 11:08 ET | Source: Daré Bioscience, Inc.

Cerulean Pharma Announces Pricing of Initial Public Offering

CAMBRIDGE, Mass., April 10, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU) today announced the pricing of its initial public offering of 8,500,000 shares of its common stock at a public...